{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:56:07Z","timestamp":1793217367246,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":122,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Circadian rest\u2013activity rhythm disruption and sleep\u2013wake fragmentation are common in Alzheimer\u2019s disease (AD) and may precede clinical diagnosis. Wrist-worn accelerometry enables objective, scalable circadian phenotyping in population cohorts. We examined whether AD polygenic risk and\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 dose are reflected in accelerometry-derived circadian phenotypes and whether these phenotypes predict subsequent incident dementia\/AD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 94,241 UK Biobank participants with 7-day wrist accelerometry and genetic data. Circadian phenotypes included relative amplitude (RA), L5 and M10 start hour, interdaily stability (IS), and intradaily variability (IV). Genetic exposures were a standardized AD polygenic risk score (AD-PRS) corresponding to the dataset-provided UK Biobank AD PRS variable standardized within the analytic sample, and APOE \u03b54 dose. Cross-sectional associations were tested with linear regression. Incident dementia\/AD were modeled with Cox proportional hazards models with time zero defined as the accelerometry end date. Prespecified sensitivity analyses included lagged exclusions, competing risk of death, selection into accelerometry (inverse probability weighting), additional adjustment for overall activity, strict versus broad AD definitions, and RA\u2009\u00d7\u2009genetic-risk interaction terms in incident models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AD-PRS showed no robust association with RA or phase timing (fully adjusted standardized beta\u2009=\u20090.0028;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.358). APOE \u03b54 dose was associated with earlier M10 timing (standardized beta\u2009=\u2009-0.0074;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.032). AD-PRS showed a nominal association with IS (standardized beta\u2009=\u20090.0073;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018) that did not survive multiple-testing correction. In incident analyses (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200980,378; 949 dementia and 371\n                      <jats:sc>AD<\/jats:sc>\n                      events), AD-PRS and APOE \u03b54 dose strongly predicted incident dementia and incident AD. Each 1-SD higher RA was associated with lower risk of incident dementia (HR\u2009=\u20090.80 per SD;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20094.99\u2009\u00d7\u200910\n                      <jats:sup>\u201319<\/jats:sup>\n                      ) and incident AD (HR\u2009=\u20090.90;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031), meaning that lower RA corresponded to higher risk. The RA\u2013dementia association remained stable across sensitivity analyses, whereas the RA\u2013AD association attenuated after additional adjustment for overall activity. We found no evidence that RA associations differed by AD-PRS or APOE \u03b54 dose in incident interaction analyses (all interaction\n                      <jats:italic>p<\/jats:italic>\n                      values\u2009\u2265\u20090.362).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In this population cohort, AD polygenic risk showed minimal cross-sectional association with circadian amplitude or phase, whereas\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 dose was linked to slightly earlier peak daytime activity timing. Lower circadian amplitude (RA) consistently predicted higher subsequent dementia risk across multiple bias-oriented sensitivity analyses. For incident AD, the RA association was weaker after additional control for overall activity, supporting cautious interpretation of RA as a robust behavioral risk marker for dementia rather than an AD-specific genetic interaction signal.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-026-02088-3","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:17:38Z","timestamp":1779445058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alzheimer\u2019s disease polygenic risk, APOE \u03b54 dose, and accelerometer-derived circadian rest\u2013activity rhythms in relation to incident dementia and Alzheimer\u2019s disease in UK Biobank: a prospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Simin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqian","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"1","key":"2088_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41582-021-00577-7","volume":"18","author":"M Nassan","year":"2022","unstructured":"Nassan M, Videnovic A. Circadian rhythms in neurodegenerative disorders. Nat Rev Neurol. 2022;18(1):7\u201324. https:\/\/doi.org\/10.1038\/s41582-021-00577-7.","journal-title":"Nat Rev Neurol"},{"key":"2088_CR2","doi-asserted-by":"publisher","first-page":"102514","DOI":"10.1016\/j.arr.2024.102514","volume":"101","author":"RAV Lacerda","year":"2024","unstructured":"Lacerda RAV, Desio JAF, Kammers CM, et al. Sleep disorders and risk of Alzheimer\u2019s disease: a two-way road. Ageing Res Rev. 2024;101:102514. https:\/\/doi.org\/10.1016\/j.arr.2024.102514.","journal-title":"Ageing Res Rev"},{"key":"2088_CR3","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1007\/s11357-025-01637-2","volume":"47","author":"Z Ungvari","year":"2025","unstructured":"Ungvari Z, Fekete M, Lehoczki A, et al. Sleep disorders increase the risk of dementia, Alzheimer\u2019s disease, and cognitive decline: a meta-analysis. GeroScience. 2025;47:4899\u2013920. https:\/\/doi.org\/10.1007\/s11357-025-01637-2.","journal-title":"GeroScience"},{"issue":"2","key":"2088_CR4","doi-asserted-by":"publisher","first-page":"e0169649","DOI":"10.1371\/journal.pone.0169649","volume":"12","author":"A Doherty","year":"2017","unstructured":"Doherty A, Jackson D, Hammerla N, et al. Large scale population assessment of physical activity using wrist worn accelerometers: The UK Biobank Study. PLoS ONE. 2017;12(2):e0169649. https:\/\/doi.org\/10.1371\/journal.pone.0169649.","journal-title":"PLoS ONE"},{"issue":"7","key":"2088_CR5","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1152\/japplphysiol.00421.2014","volume":"117","author":"VT van Hees","year":"2014","unstructured":"van Hees VT, Fang Z, Langford J, et al. Autocalibration of accelerometer data for free-living physical activity assessment using local gravity and temperature: an evaluation on four continents. J Appl Physiol. 2014;117(7):738\u201344. https:\/\/doi.org\/10.1152\/japplphysiol.00421.2014.","journal-title":"J Appl Physiol"},{"issue":"3","key":"2088_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1123\/jmpb.2018-0063","volume":"2","author":"JH Migueles","year":"2019","unstructured":"Migueles JH, Rowlands AV, Huber F, Sabia S, van Hees VT. GGIR: a research community\u2013driven open source R package for generating physical activity and sleep outcomes from multi-day raw accelerometer data. J Meas Phys Behav. 2019;2(3):188\u201396. https:\/\/doi.org\/10.1123\/jmpb.2018-0063.","journal-title":"J Meas Phys Behav"},{"key":"2088_CR7","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","volume":"30","author":"J Fortea","year":"2024","unstructured":"Fortea J, Pegueroles J, Alcolea D, et al. APOE4 homozygosity represents a distinct genetic form of Alzheimer\u2019s disease. Nat Med. 2024;30:1284\u201391. https:\/\/doi.org\/10.1038\/s41591-024-02931-w.","journal-title":"Nat Med"},{"issue":"4","key":"2088_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336. https:\/\/doi.org\/10.1038\/s41588-022-01024-z.","journal-title":"Nat Genet"},{"issue":"1","key":"2088_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41576-023-00637-2","volume":"25","author":"L Kachuri","year":"2024","unstructured":"Kachuri L, Chatterjee N, Hirbo J, et al. Principles and methods for transferring polygenic risk scores across global populations. Nat Rev Genet. 2024;25(1):8\u201325. https:\/\/doi.org\/10.1038\/s41576-023-00637-2.","journal-title":"Nat Rev Genet"},{"issue":"7849","key":"2088_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-021-03243-6","volume":"591","author":"H Wand","year":"2021","unstructured":"Wand H, Lambert SA, Tamburro C, et al. Improving reporting standards for polygenic scores in risk prediction studies. Nature. 2021;591(7849):211\u20139. https:\/\/doi.org\/10.1038\/s41586-021-03243-6.","journal-title":"Nature"},{"issue":"3","key":"2088_CR11","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"},{"issue":"7726","key":"2088_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139. https:\/\/doi.org\/10.1038\/s41586-018-0579-z.","journal-title":"Nature"},{"issue":"10","key":"2088_CR13","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296.","journal-title":"PLoS Med"},{"issue":"2","key":"2088_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Series B Stat Methodol. 1972;34(2):187\u2013220.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"1","key":"2088_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"6","key":"2088_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10654-019-00499-1","volume":"34","author":"T Wilkinson","year":"2019","unstructured":"Wilkinson T, Schnier C, Bush K, et al. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol. 2019;34(6):557\u201365. https:\/\/doi.org\/10.1007\/s10654-019-00499-1.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"2088_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/pcn.13671","volume":"78","author":"Y Liu","year":"2024","unstructured":"Liu Y, Feng H, Du J, et al. Associations between accelerometer-measured circadian rest-activity rhythm, brain structural and genetic mechanisms, and dementia. Psychiatry Clin Neurosci. 2024;78(7):393\u2013404. https:\/\/doi.org\/10.1111\/pcn.13671.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"2088_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13195-024-01411-0","volume":"16","author":"JR Winer","year":"2024","unstructured":"Winer JR, Lok R, Weed L, et al. Impaired 24-h activity patterns are associated with an increased risk of Alzheimer\u2019s disease, Parkinson\u2019s disease, and cognitive decline. Alzheimers Res Ther. 2024;16(1):35. https:\/\/doi.org\/10.1186\/s13195-024-01411-0.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"2088_CR19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/ana.26617","volume":"93","author":"L Gao","year":"2023","unstructured":"Gao L, Li P, Gaykova N, et al. Circadian rest-activity rhythms, delirium risk, and progression to dementia. Ann Neurol. 2023;93(6):1145\u201357. https:\/\/doi.org\/10.1002\/ana.26617.","journal-title":"Ann Neurol"},{"issue":"2","key":"2088_CR20","doi-asserted-by":"publisher","first-page":"e214513","DOI":"10.1212\/WNL.0000000000214513","volume":"106","author":"W Wang","year":"2026","unstructured":"Wang W, Wanigatunga AA, Etzkorn LH, et al. Association between circadian rest-activity rhythms and incident dementia in older adults: The Atherosclerosis Risk in Communities Study. Neurology. 2026;106(2):e214513. https:\/\/doi.org\/10.1212\/WNL.0000000000214513.","journal-title":"Neurology"},{"key":"2088_CR21","doi-asserted-by":"publisher","first-page":"952204","DOI":"10.3389\/fnins.2022.952204","volume":"16","author":"JA Rabinowitz","year":"2022","unstructured":"Rabinowitz JA, An Y, He L, et al. Associations of circadian rest\/activity rhythms with cognition in middle-aged and older adults: demographic and genetic interactions. Front Neurosci. 2022;16:952204. https:\/\/doi.org\/10.3389\/fnins.2022.952204.","journal-title":"Front Neurosci"},{"issue":"6","key":"2088_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.neuron.2025.02.004","volume":"113","author":"S Parhizkar","year":"2025","unstructured":"Parhizkar S, Holtzman DM. The night\u2019s watch: exploring how sleep protects against neurodegeneration. Neuron. 2025;113(6):817\u201337. https:\/\/doi.org\/10.1016\/j.neuron.2025.02.004.","journal-title":"Neuron"},{"key":"2088_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41467-026-68374-8","volume":"17","author":"P Dagum","year":"2026","unstructured":"Dagum P, Elbert DL, Giovangrandi L, et al. The glymphatic system clears amyloid beta and tau from brain to plasma in humans. Nat Commun. 2026;17:715. https:\/\/doi.org\/10.1038\/s41467-026-68374-8.","journal-title":"Nat Commun"},{"key":"2088_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12987-025-00698-x","volume":"22","author":"T Lyckenvik","year":"2025","unstructured":"Lyckenvik T, Olsson M, Forsberg M, et al. Sleep reduces CSF concentrations of beta-amyloid and tau: a randomized crossover study in healthy adults. Fluids Barriers CNS. 2025;22:84. https:\/\/doi.org\/10.1186\/s12987-025-00698-x.","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"2088_CR25","doi-asserted-by":"publisher","first-page":"e182931","DOI":"10.1172\/JCI182931","volume":"135","author":"G Canet","year":"2025","unstructured":"Canet G, Da Gama Monteiro F, Rocaboy E, et al. Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. J Clin Invest. 2025;135(7):e182931. https:\/\/doi.org\/10.1172\/JCI182931.","journal-title":"J Clin Invest"},{"issue":"5","key":"2088_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, van der Flier WM, Jessen F, et al. Neuroinflammation in Alzheimer disease. Nat Rev Immunol. 2025;25(5):321\u201352. https:\/\/doi.org\/10.1038\/s41577-024-01104-7.","journal-title":"Nat Rev Immunol"},{"key":"2088_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber J, Cooper S, Liu JZ, et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat Genet. 2021;53:392\u2013402. https:\/\/doi.org\/10.1038\/s41588-020-00776-w.","journal-title":"Nat Genet"},{"issue":"446","key":"2088_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144.","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"2088_CR29","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16(3):1141\u201354. https:\/\/doi.org\/10.1214\/aos\/1176350951.","journal-title":"Ann Stat"},{"issue":"6","key":"2088_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/gepi.22418","volume":"45","author":"PM Carry","year":"2021","unstructured":"Carry PM, Vanderlinden LA, Dong F, et al. Inverse probability weighting is an effective method to address selection bias during the analysis of high dimensional data. Genet Epidemiol. 2021;45(6):593\u2013603. https:\/\/doi.org\/10.1002\/gepi.22418.","journal-title":"Genet Epidemiol"},{"issue":"1","key":"2088_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1214\/20-AOAS1386","volume":"15","author":"T Thaweethai","year":"2021","unstructured":"Thaweethai T, Arterburn DE, Coleman KJ, Haneuse S. Robust inference when combining inverse-probability weighting and multiple imputation to address missing data with application to an electronic health records-based study of bariatric surgery. Ann Appl Stat. 2021;15(1):126\u201347. https:\/\/doi.org\/10.1214\/20-AOAS1386.","journal-title":"Ann Appl Stat"},{"key":"2088_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12966-023-01464-8","volume":"20","author":"Q Zhong","year":"2023","unstructured":"Zhong Q, Zhou R, Huang YN, et al. The independent and joint association of accelerometer-measured physical activity and sedentary time with dementia: a cohort study in the UK Biobank. Int J Behav Nutr Phys Act. 2023;20:59. https:\/\/doi.org\/10.1186\/s12966-023-01464-8.","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"5","key":"2088_CR33","doi-asserted-by":"publisher","first-page":"e70244","DOI":"10.1002\/alz.70244","volume":"21","author":"AAS Laurell","year":"2025","unstructured":"Laurell AAS, Mak E, Dounavi M-E, et al. Hypothalamic volume, sleep, and APOE genotype in cognitively healthy adults. Alzheimers Dement. 2025;21(5):e70244. https:\/\/doi.org\/10.1002\/alz.70244.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"2088_CR34","doi-asserted-by":"publisher","first-page":"zsae094","DOI":"10.1093\/sleep\/zsae094","volume":"47","author":"C Andr\u00e9","year":"2024","unstructured":"Andr\u00e9 C, Martineau-Dussault M-\u00c8, Baril A-A, et al. Reduced rapid eye movement sleep in late middle-aged and older apolipoprotein E \u025b4 allele carriers. Sleep. 2024;47(7):zsae094. https:\/\/doi.org\/10.1093\/sleep\/zsae094.","journal-title":"Sleep"},{"issue":"17","key":"2088_CR35","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1212\/WNL.0000000000003255","volume":"87","author":"LL Drogos","year":"2016","unstructured":"Drogos LL, Gill SJ, Tyndall AV, et al. Evidence of association between sleep quality and APOE \u03b54 in healthy older adults: a pilot study. Neurology. 2016;87(17):1836\u201342. https:\/\/doi.org\/10.1212\/WNL.0000000000003255.","journal-title":"Neurology"},{"key":"2088_CR36","doi-asserted-by":"publisher","first-page":"7961","DOI":"10.1038\/s41598-018-26174-1","volume":"8","author":"M Willetts","year":"2018","unstructured":"Willetts M, Hollowell S, Aslett L, Holmes C, Doherty A. Statistical machine learning of sleep and physical activity phenotypes from sensor data in 96,220 UK Biobank participants. Sci Rep. 2018;8:7961. https:\/\/doi.org\/10.1038\/s41598-018-26174-1.","journal-title":"Sci Rep"},{"key":"2088_CR37","doi-asserted-by":"publisher","unstructured":"van Hees VT, Migueles JH. GGIR (version 3.1-4) [software]. Zenodo. 2024. https:\/\/doi.org\/10.5281\/zenodo.13643547.","DOI":"10.5281\/zenodo.13643547"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02088-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:35:43Z","timestamp":1790840143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02088-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02088-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was conducted using the UK Biobank Resource under application 1162548. UK Biobank has ethics approval from the North West Multi-centre Research Ethics Committee (Ref 11\/NW\/0382), and all participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"219"}}